SUNSHINE BIOPHARMA INC (SBFM) Forecast, Price Target & Analyst Ratings

NASDAQ:SBFM • US8677817004

Current stock price

0.9665 USD
-0.01 (-1.37%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SUNSHINE BIOPHARMA INC (SBFM).

Forecast Snapshot

Consensus Price Target

Price Target
$6.12
+ 533.21% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 13, 2026
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$6.12
Upside
+ 533.21%
From current price of $0.97 to mean target of $6.12, Based on 7 analyst forecasts
Low
$6.06
Median
$6.12
High
$6.30

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for SBFM. The average price target is 6.12 USD. This implies a price increase of 533.21% is expected in the next year compared to the current price of 0.9665.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

SBFM Current Analyst RatingSBFM Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

SBFM Historical Analyst RatingsSBFM Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
SBFM was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about SBFM.
In the previous month the buy percentage consensus was at a similar level.
SBFM was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-10-08Aegis CapitalReiterate Buy -> Buy
2024-12-05Aegis CapitalReiterate Buy -> Buy
2023-08-07Aegis CapitalInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 13, 2026

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026
Revenue
YoY % growth
SBFM revenue by date.SBFM revenue by date.
24.093M
454.37%		34.874M
44.75%		36.306M
4.11%		51M
40.47%
EBITDA
YoY % growth
SBFM ebitda by date.SBFM ebitda by date.
-4.636M
46.40%		-5.589M
-20.55%		-4.147M
25.80%		N/A
EBIT
YoY % growth
SBFM ebit by date.SBFM ebit by date.
-4.785M
44.84%		-5.812M
-21.46%		-4.479M
22.94%		1.734M
138.72%
Operating Margin
SBFM operating margin by date.SBFM operating margin by date.
-19.86%-16.67%-12.34%3.40%
EPS
YoY % growth
SBFM eps by date.SBFM eps by date.
N/A-51.88
84.11%		N/A
98.01%		-0.33
68.32%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

SBFM Yearly Revenue VS EstimatesSBFM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M 50M
SBFM Yearly EPS VS EstimatesSBFM Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 -100 -200 -300

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

SUNSHINE BIOPHARMA INC / SBFM Forecast FAQ

Can you provide the average price target for SUNSHINE BIOPHARMA INC stock?

7 analysts have analysed SBFM and the average price target is 6.12 USD. This implies a price increase of 533.21% is expected in the next year compared to the current price of 0.9665.

When does SUNSHINE BIOPHARMA INC (SBFM) report earnings?

SUNSHINE BIOPHARMA INC (SBFM) will report earnings on 2026-05-13.

Can you provide the consensus rating for SUNSHINE BIOPHARMA INC stock?

The consensus rating for SUNSHINE BIOPHARMA INC (SBFM) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.